Hubei Jumpcan Pharma

ISIN CNE0000018X6

 | 

WKN A0M4HF

Market cap (in EUR)
2,961 m
Country
China
Sector
Healthcare
Dividend yield
7.96%
 

Overview

Description

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs & pharmaceutical products. Its product covers the pediatrics, breathing, and digestion field. The company was founded on January 22, 1997 and is headquartered in Taizhou, China.
Show more Show less
Healthcare Healthcare Services Miscellaneous Healthcare China

Financials

Key metrics

Market capitalisation, EUR 2,961 m
EPS, EUR 0.23
P/B ratio 1.7
P/E ratio 14.6
Dividend yield 7.96%

Income statement (2024)

Revenue, EUR 1,018 m
Net income, EUR 325 m
Profit margin 31.96%

What ETF is Hubei Jumpcan Pharma in?

There are 4 ETFs which contain Hubei Jumpcan Pharma. All of these ETFs are listed in the table below. The ETF with the largest weighting of Hubei Jumpcan Pharma is the JPMorgan China A Research Enhanced Index Equity (ESG) UCITS ETF USD (dist).
ETF Weight Investment focus Fund size (in m EUR)
JPMorgan China A Research Enhanced Index Equity (ESG) UCITS ETF USD (dist) 0.06%
Equity
China
Social/Environmental
5
Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating 0.00%
Equity
Emerging Markets
1,432
Vanguard ESG Emerging Markets All Cap UCITS ETF (USD) Distributing 0.00%
Equity
Emerging Markets
Social/Environmental
15
Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing 0.00%
Equity
Emerging Markets
2,771
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.